Skip to main content
Tech.euFundingExplorerBeta

EngMab

Exited

EngMab is tracked in the Tech.eu funding database. Based in Schwyz, Switzerland; founded 2013; active in Healthtech. Acquired by Celgene in 2016. Data as of Nov 2026.

Schwyz, SwitzerlandFounded 2013
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
May 2016
Value
€545M
Acquiror
Celgene (United States Summit)

Related news

Similar companies

same sector, similar size

Global coverage: FundingData